The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Therapeutic RNA aptamers in clinical trials
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
Cerchia, L., Ducongé, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., de Franciscis, V., & Libri, D. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030123 · Cited by 246
RetractedTuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Adaptive Recognition by Nucleic Acid Aptamers
Hermann, T., & Patel, D. J. (2000) · Science · doi:10.1126/science.287.5454.820 · Cited by 1,650
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA
Robertson, D. L., & Joyce, G. F. (1990) · Nature · doi:10.1038/344467a0 · Cited by 1,331
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
DIVERSITY OF OLIGONUCLEOTIDE FUNCTIONS
Gold, L., Polisky, B., Uhlenbeck, O., & Yarus, M. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003555 · Cited by 805
Nishijima, K., Ng, Y.-S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S. J., Robinson, G. S., Adamis, A. P., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061237 · Cited by 707
Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M., & Gold, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136683100 · Cited by 567
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
Saint-Geniez, M., Kurihara, T., Sekiyama, E., Maldonado, A. E., & D'Amore, P. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905010106 · Cited by 530
The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
Soundararajan, S., Chen, W., Spicer, E. K., Courtenay-Luck, N., & Fernandes, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5723 · Cited by 512
Aptamers as therapeutic and diagnostic agents
Brody, E. N., & Gold, L. (2000) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(99)00004-5 · Cited by 494
Complement-targeted therapeutics
Ricklin, D., & Lambris, J. D. (2007) · Nature Biotechnology · doi:10.1038/nbt1342 · Cited by 481
Discovery and development of anticancer aptamers
Ireson, C. R., & Kelland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
Sullenger, B. A., Gallardo, H. F., Ungers, G. E., & Gilboa, E. (1990) · Cell · doi:10.1016/0092-8674(90)90455-n · Cited by 443
Mirror-image RNA that binds D-adenosine
Klußmann, S., Nolte, A., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1112 · Cited by 399
Automated selection of anti-Protein aptamers
Cox, J. C., & Ellington, A. D. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00028-1 · Cited by 367
Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF
Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 347
Jo, N., Mailhos, C., Ju, M., Cheung, E., Bradley, J., Nishijima, K., Robinson, G. S., Adamis, A. P., & Shima, D. T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050588 · Cited by 322
Discovery and Development of Therapeutic Aptamers
Bouchard, P. R., Hutabarat, R. M., & Thompson, K. M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105547 · Cited by 320
Shamah, S. M., Healy, J. M., & Cload, S. T. (2008) · Accounts of Chemical Research · doi:10.1021/ar700142z · Cited by 304
Berezovski, M., Drabovich, A., Krylova, S. M., Musheev, M., Okhonin, V., Petrov, A., & Krylov, S. N. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042394q · Cited by 298
Pharmacokinetics and Biodistribution of Novel Aptamer Compositions
Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 298
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
Gilbert, J. C., DeFeo-Fraulini, T., Hutabarat, R. M., Horvath, C. J., Merlino, P. G., Marsh, H. N., Healy, J. M., BouFakhreddine, S., Holohan, T. V., & Schaub, R. G. (2007) · Circulation · doi:10.1161/circulationaha.107.724864 · Cited by 286
Griffin, L., Tidmarsh, G., Bock, L., Toole, J., & Leung, L. (1993) · Blood · doi:10.1182/blood.v81.12.3271.3271 · Cited by 285
SELEX with modified nucleotides
Keefe, A. D., & Cload, S. T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.028 · Cited by 283
Bendele, A. M., Seely, J., Richey, C., Sennello, G., & Shopp, G. M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2396 · Cited by 279
Girvan, A. C., Teng, Y., Casson, L. K., Thomas, S. D., Jüliger, S., Ball, M. W., Klein, J. B., Pierce, W. M., Barve, S. S., & Bates, P. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0361 · Cited by 235
Specific binding of aminoglycoside antibiotics to RNA
Wang, Y., & Rando, R. R. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90047-0 · Cited by 227
Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.668434 · Cited by 222
Isolation of RNA Aptamers for Biological Cofactors by In Vitro Selection
Burgstaller, P., & Famulok, M. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199410841 · Cited by 221
Henry, S. P., Giclas, P. C., Leeds, J., Pangburn, M., Auletta, C., Levin, A. A., & Kornbrust, D. J. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36667-4 · Cited by 204
Chen, C.-H. B., Chernis, G. A., Hoang, V. Q., & Landgraf, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332660100 · Cited by 190
Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor
Jellinek, D., Green, L. S., Bell, C., & Janjic, N. (1994) · Biochemistry · doi:10.1021/bi00200a028 · Cited by 184
Wlotzka, B., Leva, S., Eschgfäller, B., Burmeister, J., Kleinjung, F., Kaduk, C., Muhn, P., Hess-Stumpp, H., & Klussmann, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132067399 · Cited by 183
Spiegelmers: Biostable Aptamers
Eulberg, D., & Klussmann, S. (2003) · ChemBioChem · doi:10.1002/cbic.200300663 · Cited by 181
Cell-Specific Aptamer-Mediated Targeted Drug Delivery
Zhou, J., & Rossi, J. J. (2011) · Oligonucleotides · doi:10.1089/oli.2010.0264 · Cited by 176
Sultan, M. B., Zhou, D., Loftus, J., Dombi, T., & Ice, K. S. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.045 · Cited by 172
Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA
Chelliserrykattil, J., & Ellington, A. D. (2004) · Nature Biotechnology · doi:10.1038/nbt1001 · Cited by 168
Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
NG, E. W. M., & ADAMIS, A. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.062 · Cited by 161
Self‐Assembled Signaling Aptamer DNA Arrays for Protein Detection
Lin, C., Katilius, E., Liu, Y., Zhang, J., & Yan, H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600438 · Cited by 153
Aptamer-based molecular recognition for biosensor development
Zhou, J., Battig, M. R., & Wang, Y. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3987-y · Cited by 148
Waters, E. K., Genga, R. M. J., Schwartz, M. C., Nelson, J. A., Schaub, R. G., Olson, K. A., Kurz, J. C., & McGinness, K. E. (2011) · Blood · doi:10.1182/blood-2010-10-311936 · Cited by 143
Zarbin, M. A., & Rosenfeld, P. J. (2010) · Retina · doi:10.1097/iae.0b013e3181f57e30 · Cited by 141
Eulberg, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni044 · Cited by 140
Chan, M. Y., Cohen, M. G., Dyke, C. K., Myles, S. K., Aberle, L. G., Lin, M. J., Walder, J. S., Steinhubl, S. R., Gilchrist, I. C., Kleiman, N. S., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.745687 · Cited by 130
Aptamers for Targeted Drug Delivery
Ray, P., & White, R. R. (2010) · Pharmaceuticals · doi:10.3390/ph3061761 · Cited by 129
Selection of Smart Aptamers by Methods of Kinetic Capillary Electrophoresis
Drabovich, A. P., Berezovski, M. V., Okhonin, V., & Krylov, S. N. (2006) · Analytical Chemistry · doi:10.1021/ac060144h · Cited by 128
In vitro selection of nucleic acids for diagnostic applications
Hesselberth, J. R., Robertson, M. P., Jhaveri, S. D., & Ellington, A. D. (2000) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(99)00005-7 · Cited by 120
Aptamers and the RNA World, Past and PresentPreprint
Gold, L., Janjić, N., Jarvis, T. C., Schneider, D., Walker, J. J., Wilcox, S. K., & Zichi, D. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003582 · Cited by 120
Phosphorothioate Oligonucleotides Inhibit the Intrinsic Tenase Complex
Sheehan, J. P., & Lan, H.-C. (1998) · Blood · doi:10.1182/blood.v92.5.1617 · Cited by 118
Patel, D. J., & Suri, A. K. (2000) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(99)00003-3 · Cited by 114
Aptamers as Tools in Molecular Biology and Immunology
Famulok, M., & Mayer, G. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60142-2_7 · Cited by 112
The potential of aptamers as anticoagulants
Nimjee, S. M., Rusconi, C. P., Harrington, R. A., & Sullenger, B. A. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.01.002 · Cited by 109
Chan, M. Y., Rusconi, C. P., Alexander, J. H., Tonkens, R. M., Harrington, R. A., & Becker, R. C. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02932.x · Cited by 108
Mechanism of Ribose 2‘-Group Discrimination by an RNA Polymerase
Huang, Y., Eckstein, F., Padilla, R. M., & Sousa, R. (1997) · Biochemistry · doi:10.1021/bi962674l · Cited by 104
Cohen, M. G., Purdy, D. A., Rossi, J. S., Grinfeld, L. R., Myles, S. K., Aberle, L. H., Greenbaum, A. B., Fry, E. T. A., Chan, M. Y., Tonkens, R. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.927756 · Cited by 100
Isolating Aptamers Using Capillary Electrophoresis–SELEX (CE–SELEX)
Mosing, R. K., & Bowser, M. T. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-557-2_3 · Cited by 76
Cell-Specific Aptamers for Targeted Therapies
Cerchia, L., Giangrande, P. H., McNamara, J. O., & de Franciscis, V. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-557-2_5 · Cited by 73
Selection of aptamers for signal transduction proteins by capillary electrophoresis
Tok, J., Lai, J., LEUNG, T. K. C., & Li, S. F. Y. (2010) · Electrophoresis · doi:10.1002/elps.200900543 · Cited by 67
Oligonucleotide libraries - variatio delectat
Famulok, M., & Jenne, A. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80004-5 · Cited by 66
Oligodeoxynucleotide Studies in Primates: Antisense and Immune Stimulatory Indications
Farman, C. A., & Kornbrust, D. J. (2003) · Toxicologic Pathology · doi:10.1080/01926230390174995 · Cited by 61
Friberg, T. R., Tolentino, M., & for the LEVEL Study Group (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.174946 · Cited by 50
Protein synthesis editing by a DNA aptamer.
Hale, S. P., & SCHIMMEL, P. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2755 · Cited by 47
Update on the first phase I study of AGRO100 in advanced cancer
Laber, D. A., Sharma, V. R., Bhupalam, L., Taft, B. S., Hendler, F. J., & Barnhart, K. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3064 · Cited by 36
L-amino acid oxidase from Naja atra venom activates and binds to human platelets
Li, R., Zhu, S.-W., Wu, J., Wang, W.-Y., Lu, Q., & Clemetson, K. J. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00372.x · Cited by 33
Synthesis and biological activities of a phosphorodithioate analog of 2′, 5′-oligoadenylate
Beigelman, L. N., Matulić‐Adamić, J., Haeberli, P., Usman, N., Dong, B., Silverman, R. H., Khamnei, S., & Torrence, P. F. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3989 · Cited by 32
Extended phase I study of AS1411 in renal and non-small cell lung cancers
Laber, D. A., Taft, B. S., Kloecker, G. H., Bates, P. J., Trent, J. O., & Miller, D. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.13098 · Cited by 30
Vavalle, J. P., Rusconi, C. P., Zelenkofske, S. L., Wargin, W. A., Alexander, J. H., & Becker, R. C. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04742.x · Cited by 28
A phase I study of AGRO100 in advanced cancer
Laber, D. A., Choudry, M. A., Taft, B. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3112 · Cited by 17
Cited by
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
Metal–Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications
Sun, Y., Zheng, L., Yang, Y., Qian, X., Fu, T., Li, X., Yang, Z., Yan, H., Cui, C., & Tan, W. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00423-3 · Cited by 723
Current approaches in SELEX: An update to aptamer selection technology
Darmostuk, M., Rimpelova, S., Gbelcova, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 702
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Replacing antibodies with aptamers in lateral flow immunoassay
Chen, A., & Yang, S. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.04.041 · Cited by 551
Metadata
- Authors
- Sundaram, P., Kurniawan, H., Byrne, M. E., & Wower, J.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 48
- Issue
- 1-2
- Pages
- 259-271
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2151442275
- Cited by
- 259
- References
- 74
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.